These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7285015)

  • 1. Repair of DNA adducts of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one in mouse tissues and its relation to tumor induction.
    Abbott PJ; Crew F
    Cancer Res; 1981 Oct; 41(10):4115-20. PubMed ID: 7285015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-specific tumorigenesis in mouse skin induced by the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, and its relation to DNA adduct formation and persistence.
    Abbott PJ
    Cancer Res; 1983 May; 43(5):2261-6. PubMed ID: 6831449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
    Kulkarni MS; Anderson MW
    Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
    Nakayama J; Yuspa SH; Poirier MC
    Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA adducts of the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, in vivo and in vitro: high pressure liquid chromatographic separation and partial characterization.
    Abbott PJ; Coombs MM
    Carcinogenesis; 1981; 2(7):629-36. PubMed ID: 7273342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the proximate and ultimate forms of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one.
    Coombs MM; Kissonerghis AM; Allen JA; Vose CW
    Cancer Res; 1979 Oct; 39(10):4160-5. PubMed ID: 476652
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the metabolism and DNA binding of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one by hamster embryo cells and the human hepatoma cell line HepG2.
    Bhatt TS
    Carcinogenesis; 1986 Jan; 7(1):143-8. PubMed ID: 3002653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of in vivo DNA repair synthesis in mouse liver and lung induced by treatment with benzo(a)pyrene or 4-nitroquinoline 1-oxide.
    Kulkarni MS; Angerman-Stewart J; Anderson MW
    Cancer Res; 1984 Apr; 44(4):1547-50. PubMed ID: 6322980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the binding of some carcinogenic and non-carcinogenic cyclopenta[a]phenanthrenes to DNA in vitro and in vivo.
    Russell JC; Bhatt TS; Jones JR; Coombs MM
    Carcinogenesis; 1985 Aug; 6(8):1223-5. PubMed ID: 4017191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitor.
    Coombs MM; Bhatt TS; Vose CW
    Cancer Res; 1975 Feb; 35(2):305-9. PubMed ID: 234032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent DNA adducts formed by benzo[c]chrysene in mouse epidermis and by benzo[c]chrysene fjord-region diol epoxides reacted with DNA and polynucleotides.
    Giles AS; Seidel A; Phillips DH
    Chem Res Toxicol; 1997 Nov; 10(11):1275-84. PubMed ID: 9403182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic and carcinogenic metabolites of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one.
    Coombs MM; Bhatt TS; Kissonerghis AM; Vose CW
    Cancer Res; 1980 Mar; 40(3):882-6. PubMed ID: 7471101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
    Blair IA; Oe T; Kambouris S; Chaudhary AK
    Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and repair of DNA adducts in vinyl chloride- and vinyl fluoride-induced carcinogenesis.
    Swenberg JA; Bogdanffy MS; Ham A; Holt S; Kim A; Morinello EJ; Ranasinghe A; Scheller N; Upton PB
    IARC Sci Publ; 1999; (150):29-43. PubMed ID: 10626206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic, topical administration of 4-aminobiphenyl induces tissue-specific DNA adducts in mice.
    Underwood PM; Zhou Q; Jaeger M; Reilman R; Pinney S; Warshawsky D; Talaska G
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):325-31. PubMed ID: 9194416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.
    Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
    Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.